SearchDictionaryMobileLogin

Radiation-Induced Neoplasms (Neoplasms, Radiation Induced)

34  relevant articles (1 outcomes, 0 trials/studies) found for this Disease

Description: Tumors, cancer or other neoplasms produced by exposure to ionizing or non-ionizing radiation.

Also Known As:
Neoplasms, Radiation Induced; Neoplasms, Radiation-Induced; Cancer, Radiation-Induced; Cancer, Radiation Induced; Cancers, Radiation-Induced; Neoplasm, Radiation-Induced; Radiation Induced Cancer; Radiation Induced Neoplasms; Radiation-Induced Cancers; Radiation-Induced Neoplasm; Radiation-Induced Cancer

Relationship Network

Disease Context: Research Results

Related Diseases

1. Goiter
2. Neoplasms (Cancer)
3. Seminoma
4. Necrosis
5. B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Experts

1. Schneider, Uwe: 1 article (01/2005)
2. Gagliardi, Giovanna: 1 article (01/2005)
3. Karlsson, Mikael: 1 article (01/2005)
4. Mu, Xiangkui: 1 article (01/2005)
5. Johansson, Lennart: 1 article (01/2005)
6. Björk-Eriksson, Thomas: 1 article (01/2005)
7. Zackrisson, Dr Björn: 1 article (01/2005)
8. Oelfke, Uwe: 1 article (01/2005)
9. Johansson, Karl-Axel: 1 article (01/2005)
10. Nill, Simeon: 1 article (01/2005)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Radiation-Induced Neoplasms:
1. IodineIBA
2. Radioisotopes (Radionuclides)IBA
3. Protons (Proton)IBA
4. IronIBA
5. Integration Host Factors (Host Factor)IBA
03/01/1981 - "Several generalizations about radiation carcinogenesis can be made: 1) a single exposure is sufficient to elevate cancer incidence many years later: 2) radiation-induced cancer cannot be distinguished from naturally occurring cancer, i.e., there is not unique radiogenic cancer; 3) all cancers appear to be increased after irradiation with the exception of chronic lymphocytic leukemia, and possibly Hodgkin's disease, cervical cancer, and a few others; 4) the breast, thyroid, and bone marrow appear especially radiosensitive; 5) leukemia is the most prominent radiogenic tumor and shows a wave-like pattern of excess incidence over time, and the excess begins within two to four years, peaks about six to eight years, and decreases to normal levels about 25 years later; 6) solid tumors have a minimum latent period of about ten years, and for several cancers, the temporal pattern of incidence appears to follow the natural incidence, i.e., the cancers do not occur before the ages normally associated with increased incidence, implying that age-dependent factors influence the expression of disease; 7) age at exposure is perhaps the most important host factor influencing subsequent cancer risk; 8) the percentage increase in cancer incidence per rad is not the same for all cancers, i.e., some cancer of high natural incidence, e.g., colon, have low "relative risks" and some cancers of low natural incidence, e.g., thyroid, have high "relative risks;" 9) dose-effect curves are often linear, but curvilinearity is also observed and is possibly associated with the need for "two ionizing events" for transformation to occur at low doses, the influence of cell sterilization at moderate doses, the likelihood of "wasted" dose at high doses, and/or the influence of factors that effect the expression of disease."
Order ALL the reference details at left...
6. Protective AgentsIBA
7. MicronutrientsIBA
8. Vitamin EFDA Link
9. UraniumIBA
10. Retinaldehyde (Retinal)IBA

Therapies and Procedures

1. Aftercare (After-Treatment)
2. Stents
3. X-Ray Therapy
4. Transcutaneous Electric Nerve Stimulation (TENS)
5. Brachytherapy

Best Treatments:
Research Summary Report
on Radiation-Induced Neoplasms
*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 1 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>